NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $617,946 | -3.0% | 6,066,617 | -3.9% | 1.06% | +3.4% |
| Q2 2023 | $637,248 | +4.8% | 6,315,010 | -4.4% | 1.03% | -2.7% |
| Q1 2023 | $607,858 | -38.8% | 6,607,149 | -39.6% | 1.06% | -46.9% |
| Q4 2022 | $993,021 | -99.9% | 10,945,998 | -26.7% | 1.99% | -13.5% |
| Q3 2022 | $1,134,811,000 | -13.3% | 14,929,752 | -3.6% | 2.30% | -5.4% |
| Q2 2022 | $1,308,966,000 | -13.8% | 15,485,220 | -10.5% | 2.43% | +19.7% |
| Q1 2022 | $1,518,706,000 | -3.0% | 17,307,187 | -3.3% | 2.03% | +7.2% |
| Q4 2021 | $1,565,150,000 | +1.1% | 17,893,566 | -5.5% | 1.89% | -0.6% |
| Q3 2021 | $1,548,868,000 | -10.7% | 18,939,445 | -0.4% | 1.90% | -9.5% |
| Q2 2021 | $1,735,348,000 | +2.7% | 19,019,589 | -3.8% | 2.10% | -3.9% |
| Q1 2021 | $1,689,835,000 | -11.0% | 19,768,777 | -1.7% | 2.19% | -12.9% |
| Q4 2020 | $1,899,717,000 | +107.9% | 20,117,729 | +91.5% | 2.51% | +88.8% |
| Q3 2020 | $913,580,000 | -0.8% | 10,505,750 | -0.4% | 1.33% | -10.0% |
| Q2 2020 | $920,923,000 | +7.3% | 10,544,119 | +1.3% | 1.48% | -16.4% |
| Q1 2020 | $858,119,000 | -11.7% | 10,407,756 | +1.4% | 1.77% | +7.0% |
| Q4 2019 | $972,005,000 | +57.5% | 10,265,132 | +44.5% | 1.65% | +39.1% |
| Q3 2019 | $617,235,000 | -3.8% | 7,102,815 | +1.1% | 1.19% | -0.8% |
| Q2 2019 | $641,739,000 | -4.8% | 7,028,136 | +0.2% | 1.20% | -9.5% |
| Q1 2019 | $674,070,000 | +12.8% | 7,011,335 | +0.7% | 1.32% | -6.1% |
| Q4 2018 | $597,594,000 | -5.6% | 6,964,149 | -5.2% | 1.41% | +13.7% |
| Q3 2018 | $632,925,000 | +16.2% | 7,345,919 | +1.9% | 1.24% | +12.6% |
| Q2 2018 | $544,620,000 | -13.7% | 7,209,699 | -7.6% | 1.10% | -17.7% |
| Q1 2018 | $630,799,000 | +8.7% | 7,802,086 | +12.8% | 1.34% | +10.8% |
| Q4 2017 | $580,574,000 | -0.6% | 6,914,888 | +1.7% | 1.21% | -5.1% |
| Q3 2017 | $583,789,000 | +5.5% | 6,800,107 | +2.5% | 1.27% | -2.3% |
| Q2 2017 | $553,541,000 | +19.4% | 6,631,613 | +6.3% | 1.30% | +12.8% |
| Q1 2017 | $463,537,000 | +2.7% | 6,241,239 | +0.7% | 1.16% | +4.1% |
| Q4 2016 | $451,570,000 | -2.2% | 6,199,477 | +6.0% | 1.11% | -5.2% |
| Q3 2016 | $461,951,000 | -0.0% | 5,850,438 | +4.4% | 1.17% | -6.8% |
| Q2 2016 | $462,156,000 | +21.7% | 5,601,211 | +6.8% | 1.26% | +16.4% |
| Q1 2016 | $379,800,000 | -8.7% | 5,242,948 | +8.5% | 1.08% | -7.9% |
| Q4 2015 | $415,915,000 | -1.6% | 4,833,976 | +5.1% | 1.17% | -6.4% |
| Q3 2015 | $422,840,000 | +0.5% | 4,600,090 | +7.6% | 1.25% | +9.0% |
| Q2 2015 | $420,617,000 | +18.0% | 4,277,164 | +18.4% | 1.15% | +16.3% |
| Q1 2015 | $356,337,000 | +9.9% | 3,613,603 | +3.3% | 0.99% | +9.9% |
| Q4 2014 | $324,164,000 | +0.4% | 3,498,428 | +2.0% | 0.90% | -5.0% |
| Q3 2014 | $322,857,000 | +16.4% | 3,429,908 | +12.0% | 0.95% | +20.2% |
| Q2 2014 | $277,260,000 | +13.4% | 3,062,631 | +6.5% | 0.79% | +13.6% |
| Q1 2014 | $244,543,000 | +49.6% | 2,876,296 | +41.4% | 0.69% | +41.1% |
| Q4 2013 | $163,473,000 | +5.9% | 2,033,745 | +1.0% | 0.49% | -1.8% |
| Q3 2013 | $154,425,000 | +152.6% | 2,013,099 | +132.9% | 0.50% | +129.4% |
| Q2 2013 | $61,132,000 | – | 864,542 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |